CRE26-065: Second-Line Treatments for Patients With Cemiplimab-Refractory Cutaneous Squamous Cell Carcinomas: A Brief Report
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Nonmelanoma Skin Cancer Studies
Cancer Immunotherapy and Biomarkers
Head and Neck Cancer Studies
Publication details
- Journal / source
- Journal of the National Comprehensive Cancer Network
- Volume
- 24
- Issue
- 3.5
- Publication date
- 27 March 2026
- Language
- EN